Amomonpon, Marjie .
HRN: 11-13-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2025
CEFUROXIME 500MG (TAB)
04/25/2025
05/01/2025
PO
500 Mg
BID
Sp RMLE And Repair, Thinly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes